stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
  • Nasdaq
  • Dow
  • S&P 500
Aspire Biopharma Holdings IncASBP
$7.309.99%-0.81

Aspire Biopharma Holdings Inc (ASBP)

Date: 2026-11-02 16:00O: 8.03H: 8.12L: 7.30C: 7.30Vol: 21.01k
Aspire Biopharma Holdings Inc stock is traded at $7.30, with a volume of 21,013. It is down -9.99% in the last 24 hours and down -16.86% over the past month. Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Previous Close:
$8.11
Open:
$8.03
24h Volume:
21,013
Relative Volume:
0.94
Market Cap:
$10.24M
Revenue:
$34,600
Net Income/Loss:
-$11.76M
P/E Ratio:
-
EPS:
-$153.56
Net Cash Flow:
-$6.21M
1W Performance:
-13.51%
1M Performance:
-16.86%
6M Performance:
+14.67%
1Y Performance:
-98.32%
1-Day Range:
$0.00$0.00
1-Week Range:
$7.30$9.14
52-Week Range:
$3.31$476.04

Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile

Name
Aspire Biopharma Holdings Inc
Industry
Auto Parts
Phone
561-704-8527
Address
23150 FASHION DRIVE, SUITE 232, ESTERO, USA
Employee
-
X
-
Next Earnings Date
2026-11-13
Latest SEC Filings
SEC
ASBP's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Aspire Biopharma Holdings Inc Stock (ASBP) Financials Data

PeriodTrendFY 2025FY 2024FY 2023FY 2022
Period End Date2025-12-312024-12-312023-12-312022-12-31
Revenue USD (M)0.01---
Cost of revenue USD (M)0.01---
Gross profit USD (M)-0.00---
Research and development USD (M)0.92---
Operating expenses USD (M)19.353.091.340.98
Operating income USD (M)-19.35---
Income before tax USD (M)-24.48---
Net income USD (M)-24.48-12.544.463.34
Diluted EPS USD/shares-16.38---
Basic weighted shares shares (M)1.49---
Diluted weighted shares shares (M)1.49---

Aspire Biopharma Holdings Inc Stock (ASBP) Latest News

Oct 20, 2026
Oct 20, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 11, 2026
Sep 11, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Aug 28, 2026
Aug 28, 2026
Aug 23, 2026
Aug 23, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026

Similar to ASBP